Aprobarbital
Aprobarbital (or aprobarbitone), sold as Oramon, Somnifaine, and Allonal, is a barbiturate derivative invented in the 1920s by Ernst Preiswerk. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1] Aprobarbital was never as widely used as more common barbiturate derivatives such as phenobarbital and is now rarely prescribed as it has been replaced by newer drugs with a better safety margin.
 | |
 | |
| Clinical data | |
|---|---|
| Other names | aprobarbital, Oramon, allylpropymal, Alurate, 5-isopropyl- 5-allylbarbituric acid |
| AHFS/Drugs.com | International Drug Names |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.908  |
| Chemical and physical data | |
| Formula | C10H14N2O3 |
| Molar mass | 210.233 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
See also
- Alphenal
References
- Reddemann H, Turk E. Oramon poisoning in infancy and childhood. Observations on 12 aprobarbital poisonings (German). Das Deutsche Gesundheitswesen. 1966 May 12;21(19):878-81.
GABAA receptor positive modulators | |
|---|---|
| Alcohols |
|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates |
|
| Flavonoids | |
| Imidazoles |
|
| Kava constituents |
|
| Monoureides |
|
| Neuroactive steroids |
|
| Nonbenzodiazepines |
|
| Phenols | |
| Piperidinediones |
|
| Pyrazolopyridines |
|
| Quinazolinones |
|
| Volatiles/gases |
|
| Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators | |
Hypnotics/sedatives (N05C) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GABAA |
| ||||||||||||||||||||||||
| GABAB |
| ||||||||||||||||||||||||
| H1 |
| ||||||||||||||||||||||||
| α2-Adrenergic |
| ||||||||||||||||||||||||
| 5-HT2A |
| ||||||||||||||||||||||||
| Melatonin | |||||||||||||||||||||||||
| Orexin |
| ||||||||||||||||||||||||
| α2δ VDCC |
| ||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||
GABAA receptor positive modulators | |
|---|---|
| Alcohols |
|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates |
|
| Flavonoids | |
| Imidazoles |
|
| Kava constituents |
|
| Monoureides |
|
| Neuroactive steroids |
|
| Nonbenzodiazepines |
|
| Phenols | |
| Piperidinediones |
|
| Pyrazolopyridines |
|
| Quinazolinones |
|
| Volatiles/gases |
|
| Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.